TY - JOUR
T1 - Magnetic Resonance Imaging-negative Encephalomyeloradiculopathy Diagnosed by Anti-lactosylceramide Antibody Positivity and Electrophysiological Findings
T2 - A Case Report and Review of the Literature
AU - Fujioka, Hiroki
AU - Takahashi, Hisashi
AU - Ishii, Kenta
AU - Nishida, Yuki
AU - Kitaoji, Takamasa
AU - Tanaka, Eijirou
AU - Noto, Yuichi
AU - Kasai, Takashi
AU - Mutoh, Tatsuro
AU - Ohara, Tomoyuki
N1 - Publisher Copyright:
© 2026 The Japanese Society of Internal Medicine.
PY - 2026
Y1 - 2026
N2 - A 71-year-old woman developed progressive limb weakness and sensory disturbances below the thoracic level. Although myelopathy was initially considered, spinal magnetic resonance imaging (MRI) showed no abnormalities. Conversely, electrophysiological studies have identified both spinal dysfunction and radiculopathy, suggesting myeloradiculopathy. Initiation of steroid therapy resulted in immediate improvement of clinical symptoms and electrophysiological findings. Finally, anti-lactosylceramide (LacCer) antibodies were detected in the serum and cerebrospinal fluid, and titer changes correlated well with clinical improvement. This case suggests that electrophysiological studies and anti-LacCer antibodies are helpful in diagnosing and evaluating the therapeutic effects in cases of MRI-negative encephalomyeloradiculopathy.
AB - A 71-year-old woman developed progressive limb weakness and sensory disturbances below the thoracic level. Although myelopathy was initially considered, spinal magnetic resonance imaging (MRI) showed no abnormalities. Conversely, electrophysiological studies have identified both spinal dysfunction and radiculopathy, suggesting myeloradiculopathy. Initiation of steroid therapy resulted in immediate improvement of clinical symptoms and electrophysiological findings. Finally, anti-lactosylceramide (LacCer) antibodies were detected in the serum and cerebrospinal fluid, and titer changes correlated well with clinical improvement. This case suggests that electrophysiological studies and anti-LacCer antibodies are helpful in diagnosing and evaluating the therapeutic effects in cases of MRI-negative encephalomyeloradiculopathy.
KW - anti-lactosylceramide antibody
KW - electrophysiological studies
KW - encephalomyeloradiculoneuropathy
UR - https://www.scopus.com/pages/publications/105031615469
UR - https://www.scopus.com/pages/publications/105031615469#tab=citedBy
U2 - 10.2169/internalmedicine.5166-24
DO - 10.2169/internalmedicine.5166-24
M3 - Article
C2 - 40769894
AN - SCOPUS:105031615469
SN - 0918-2918
VL - 65
SP - 726
EP - 731
JO - Internal Medicine
JF - Internal Medicine
IS - 5
ER -